Economic Impact of Allergic Diseases and Asthma—The HEAD Pan‐European Registry

• DOI: 10.1111/all.16596
• Publication Date: 2025-05-20T11:49:59Z
• Authors: Ioana Agache; Maria Torres; Ibon Eguiluz‐Gracia; Elena Bradatan; Kamal El Abd; Maria Beatrice Bilo; Federica Rivolta; Andrea Sangalli; Roxana Bumbacea; Selda Ali; Dario Antolin; Águeda Concepción...; Vicente Albéndiz; Maria Miguel Oliv...; Paulo Jorge Nogueira; Loreto Carmona
• Keywords: Allergic asthma

ABSTRACT The Health Economics of Allergic Diseases (HEAD) registry is a European‐based developed by the European Academy Allergy and Clinical Immunology in collaboration with national allergy societies to facilitate standardised allergic disease management. Using an observational design, this first registry‐based study describes care patterns for diseases their impact on healthcare system (diagnostic management costs), society (missed work/school days disability pension/support) patients (out‐of‐pocket costs) 778 adults children rhinitis, asthma, atopic dermatitis food allergy, from four countries (Belgium, Italy, Romania Spain). average total costs per patient year were €1329.55 ± 1947.39, indirect €338.68 1629.61. Direct consisted €82.74 585.90 hospitalisations, €17.50 125.07 emergency department, €172.94 323.17 specialists, €22.70 132.42 primary care, €4.85 136.84 psychologists, €21.24 82.47 diagnosis €104.81 469.26 treatments. Indirect out‐of‐pocket consultation fees (€16.24 106.40), medications (€161.90 710.58), transportation (€44.15 218.51), private insurance (€16.77 157.91), avoidance (€8.65 92.99) environmental control (€99.33 955.23). Adults missed 1.02 3.20 workdays, 0.53 2.18 schooldays burdened families 1.38 13.83 lost days. There was high degree heterogeneity across costs. significant burden calls immediate action better